Key facts
- This page summarizes Jing L. Marantz's Form 4 filing for Scholar Rock Holding Corp (SRRK).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Mar 2025, 17:00.
Jing L. Marantz - 10 Mar 2025 Form 4 Insider Report for Scholar Rock Holding Corp (SRRK)
- Reporting relationship
- CHIEF MEDICAL OFFICER
- Issuer ticker
- SRRK
- Reported as of
- 10 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2025, 17:00:17 UTC
- Prior SEC filing
- 21 Jan 2025
- Next SEC filing
- 11 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Junlin Ho, Attorney-in-Fact for Jing L. Marantz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jing L. Marantz filed Form 4 for Scholar Rock Holding Corp (SRRK) on 12 Mar 2025.
Change
- Previous filing in this sequence was filed on 21 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRRK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +34,285
- Change %
- +51%
- Price
- $0.000000
- Shares after
- 101,485
- Date
- 10 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SRRK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +45,715
- Change %
- Price
- $0.000000
- Shares after
- 45,715
- Date
- 10 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,715
- Exercise price
- $35.15
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on February 15, 2026 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.
Footnote F2
Consists of 12,558 shares of common stock and 88,927 RSUs
Footnote F3
Options to vest in sixteen quarterly installments over four years, with the first quarterly installment to vest on April 1, 2025 and each additional installment to vest quarterly thereafter; provided the individual continues to have a service relationship with the Issuer on such vesting date.